These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Preliminary success using hydrogen peroxide to treat Atlantic salmon, Salmo salar L., affected with experimentally induced amoebic gill disease (AGD). Adams MB; Crosbie PB; Nowak BF J Fish Dis; 2012 Nov; 35(11):839-48. PubMed ID: 22882640 [TBL] [Abstract][Full Text] [Related]
47. Generation of Paramoeba perurans clonal cultures using flow cytometry and confirmation of virulence. Collins C; Hall M; Bruno D; Sokolowska J; Duncan L; Yuecel R; McCarthy U; Fordyce MJ; Pert CC; McIntosh R; MacKay Z J Fish Dis; 2017 Mar; 40(3):351-365. PubMed ID: 27524425 [TBL] [Abstract][Full Text] [Related]
48. Resistance to amoebic gill disease (AGD) is characterised by the transcriptional dysregulation of immune and cell cycle pathways. Wynne JW; O'Sullivan MG; Stone G; Cook MT; Nowak BF; Lovell DR; Taylor RS; Elliott NG Dev Comp Immunol; 2008; 32(12):1539-60. PubMed ID: 18621418 [TBL] [Abstract][Full Text] [Related]
49. Oxidative stress is associated with late-stage amoebic gill disease in farmed Atlantic salmon (Salmo salar L.). Marcos-López M; Espinosa CR; Rodger HD; O'Connor I; MacCarthy E; Esteban MA J Fish Dis; 2018 Feb; 41(2):383-387. PubMed ID: 28836667 [No Abstract] [Full Text] [Related]
50. Evaluation of bithionol as a bath treatment for amoebic gill disease caused by Neoparamoeba spp. Florent RL; Becker JA; Powell MD Vet Parasitol; 2007 Mar; 144(3-4):197-207. PubMed ID: 17129675 [TBL] [Abstract][Full Text] [Related]
51. Amoebic gill disease (AGD)-affected Atlantic salmon, Salmo salar L., are resistant to subsequent AGD challenge. Vincent BN; Morrison RN; Nowak BF J Fish Dis; 2006 Sep; 29(9):549-59. PubMed ID: 16948705 [TBL] [Abstract][Full Text] [Related]
52. Effects of temperature on amoebic gill disease development: Does it play a role? Benedicenti O; Pottinger TG; Collins C; Secombes CJ J Fish Dis; 2019 Sep; 42(9):1241-1258. PubMed ID: 31206728 [TBL] [Abstract][Full Text] [Related]
53. Effects of cnidarian biofouling on salmon gill health and development of amoebic gill disease. Bloecher N; Powell M; Hytterød S; Gjessing M; Wiik-Nielsen J; Mohammad SN; Johansen J; Hansen H; Floerl O; Gjevre AG PLoS One; 2018; 13(7):e0199842. PubMed ID: 29979703 [TBL] [Abstract][Full Text] [Related]
54. Pseudocyst formation in the marine parasitic amoeba Neoparamoeba perurans: a short-term survival strategy to abrupt salinity variation. Lima PC; Taylor RS; Cook M J Fish Dis; 2017 Aug; 40(8):1109-1113. PubMed ID: 28000922 [No Abstract] [Full Text] [Related]
55. Amoebic gill disease resistance is not related to the systemic antibody response of Atlantic salmon, Salmo salar L. Taylor RS; Crosbie PB; Cook MT J Fish Dis; 2010 Jan; 33(1):1-14. PubMed ID: 19943840 [TBL] [Abstract][Full Text] [Related]
56. Cardiovascular responses of three salmonid species affected with amoebic gill disease (AGD). Leef MJ; Harris JO; Hill J; Powell MD J Comp Physiol B; 2005 Oct; 175(7):523-32. PubMed ID: 16088392 [TBL] [Abstract][Full Text] [Related]
57. Description of an Atlantic salmon (Salmo salar L.) type II interleukin-1 receptor cDNA and analysis of interleukin-1 receptor expression in amoebic gill disease-affected fish. Morrison RN; Young ND; Nowak BF Fish Shellfish Immunol; 2012 Jun; 32(6):1185-90. PubMed ID: 22433573 [TBL] [Abstract][Full Text] [Related]